SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is gaining significant traction following its live integration with Bridge, a Stripe-owned fiat anchor, enabling seamless USD and EUR transactions directly on its high-throughput mainnet. This positions Keeta as essential, compliance-first infrastructure for institutional-grade settlement and cross-chain interoperability, garnering community sentiment as a currently undervalued asset with substantial asymmetric upside potential in global finance.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is experiencing elevated discussion after its major depressive disorder candidate failed a Phase 2 trial, an outcome many investors had anticipated. Community focus has quickly pivoted to the company's epilepsy and obesity programs as the next significant catalysts, alongside positive early data for its cancer drug. This sentiment is reinforced by recent significant insider purchases, signaling strong management confidence in the company's diverse pipeline.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano (ADA) is a hot topic, facing significant community skepticism with many users labeling it a "scam" or "dead chain" amidst calls to sell. Conversely, proponents point to its research-driven foundation and the recent launch of ecosystem projects like Midnight ($NIGHT) as reasons for a potential rebound. The debate underscores its position as a long-term, community-focused blockchain against a market increasingly demanding high-speed, institutionally compliant solutions.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros (OMER) is trending high after securing FDA approval for Yartemlea, marking it as the first and only approved therapy for life-threatening transplant-associated thrombotic microangiopathy (TA-TMA) in adults and children. The market is buzzing with excitement over this de-risking event, with significant community discussion around a potential short squeeze, a future valuation reset, and speculation about a buyout by Novo Nordisk, given their existing multi-billion dollar partnership.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending with mixed community sentiment, highlighting its role as a beloved, community-driven meme token amidst ongoing comparisons to emerging infrastructure projects like Keeta, which emphasizes high-performance and regulatory compliance. Investors are actively discussing SHIB's potential for significant price movements while also contrasting its market position with the utility and institutional appeal of new, robust blockchain solutions.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax Technologies is surging following the announcement of its acquisition by Sanofi, which will integrate its Heplisav-B vaccine and promising shingles candidate into a major pharmaceutical pipeline. While long-term shareholders express mixed feelings about the acquisition price, the community is actively discussing whether the offer fully captures DVAX's value and the implications for its recent licensing agreements in the context of broader biotech M&A.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

SQD is trending as the community eagerly awaits the anticipated Tokenomics 2.0 release, expected to enhance its utility and value by tying rewards to real data demand across AI, DeFi, and RWA. The recent acquisition by Rezolve Ai highlights SQD's foundational role as a decentralized blockchain data platform, driving discussions around its potential to become a cross-chain standard.

Aptos is a new, independent high-performance PoS Layer 1 project focused on delivering the safest and most scalable Layer 1 blockchain in the world. The Aptos blockchain leverages the Move programming language and the Move VM for application development, which are created and optimized for blockchain use cases.The team is comprised of the original creators, researchers, designers, and builders of Diem, the blockchain that was first built to serve this purpose. Aptos raised $200m from a16z, Multicoin, Binance and others. Aptos launched Devnet in mid March, incentivized testnet in late May and targets Q3 for mainnet launch.

Aptos

Aptos is a trending topic as discussion intensifies around its role as a high-performance Layer 1, recognized for its robust engineering and dApp capabilities. Simultaneously, significant attention is on Keeta, an emerging Layer 1 praised for its ultra-high transaction speeds, compliance-first design, and crucial fiat integration via a Stripe partnership, positioning it as a complementary, undervalued asset for global financial infrastructure alongside Aptos.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos ($ATOM) is currently trending amidst intense community debate comparing its "internet of blockchains" vision with emerging networks like Keeta ($KTA). Discussions highlight Keeta's compliance-first architecture and high-throughput capabilities for institutional financial settlements, leading many to question ATOM's long-term value accrual despite its staking rewards and ongoing tokenomics redesign efforts. The conversation pivots around whether ATOM's modularity can compete with specialized infrastructure focused on seamless traditional finance integration.

ProShares Trust - ProShares Ultra Gold 2x Shares

ProShares Ultra Gold

ProShares Ultra Gold (UGL) is trending as investors eye gold as a hedge against persistent inflation, a weakening dollar, and global uncertainties. The community is actively discussing gold's potential for further gains, with some citing strong demand from China for precious metals and silver's perceived undervaluation. Many see UGL as a leveraged opportunity to capitalize on gold's safe-haven appeal in the current market climate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mercedes Reaches Claim Settlement With US Amid Falling Q3 Sales

Mercedes-Benz Group AG settles a $149.6M U.S. diesel emissions case, ending years of legal trouble as Q3 revenues and vehicle sales slide.

Richtech Robotics and Lululemon have been highlighted as Zacks Bull and Bear of the Day

Richtech Robotics Surges on Growth Hopes While Lululemon Sees Decline.

US Slashes EU Vehicle Tariffs to 15% Under New Trade Terms

The United States cuts EU vehicle tariffs to 15% retroactive to Aug. 1, as automakers like Volkswagen, Porsche, Mercedes, and Renault lower outlooks.

IAA Mobility 2025: Volkswagen, BMW, Mercedes, BYD & XPeng Shine

IAA Mobility 2025 in Munich showcased VWAGY, BMW, MBGYY, BYDDY and XPEV, highlighting the latest EVs, AI tech, and charging innovations.

Smart, the joint venture between Mercedes-Benz and China’s Geely, will launch a new two-seat electric vehicle in late 2026 as the successor to its ForTwo city car.The model, called the Smart #2, will be introduced in China, Europe and other overseas markets. It will be a two-door, two-seat vehicle positioned in the A-segment, the company said.The car is being designed by Mercedes-Benz and engineered on a new architecture developed by Smart’s R&amp;D team for ultra-compact models. Production will take place in China.The #2 will join the existing Smart #1, #3 and #5 in the brand’s lineup. Current Smart models in mainland China are priced between 154,900 yuan ($21,700) and 368,000 yuan, CnEVPost&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://cnevpost.com/2025/09/02/smart-2-debut-2026/">reported</a>.Global CEO Tong Xiangbei said developing an ultra-compact EV on a new architecture was more complex than building larger cars, but added that the company was now ready after strengthening its production and development capabilities.The first Smart ForTwo&nbsp;was launched in 1998 and has sold over 2 million cars globally. In 2020, Mercedes-Benz reached an agreement with Chinese automaker Geely to give Smart a fresh start, with the two companies establishing a joint venture in Ningbo, Zhejiang.&nbsp;Under the deal, Mercedes handles the design while Geely takes care of engineering and production.On Stocktwits, retail sentiment for Geely was ‘bullish’ amid ‘low’ message volume.<a href="https://stocktwits.com/symbol/GELYY">Geely’s U.S.-listed stock</a> has risen 37.3% so far in 2025.($1=7.12 yuan)For updates and corrections, email newsroom[at]stocktwits[dot]com.

A smart brand new energy intelligent electric vehicle jointly owned by Mercedes-Benz and Geely Auto Group is displayed inside China's first new energy vehicle block. (Photo credit should read CFOTO/Future Publishing via Getty Images)

Geely And Mercedes To Bring Back Two-Seater Legacy With Smart #2 EV In 2026

The Smart #2 will be designed by Mercedes-Benz, engineered and built by Geely in China, and sold in China, Europe and other overseas markets.

Equity

European stocks slip marginally lower; earnings, growth data in focus

UK's 650 Million GBP Electric Car Grant: But Will It Be Enough?

UK's 650M GBP Electric Car Grant offers up to 3,750 GBP off EVs under 37,000 GBP. Will automakers and chargers keep pace?

German carmaker shares fall after Trump tariff announcement

Investing.com -- Shares of German automakers fell on Monday after U.S. President Donald Trump threatened sweeping new tariffs on European imports, with no exemptions for autos, which are already subject to a 27.5% duty.

Bernstein flags growing divide in global EV market in 2025 outlook

UBS lifts European auto stock targets as tariff impact eases

Mercedes-Benz Group AG engages in the business of manufacturing and distributing premium cars. It operates through the following segments: Mercedes-Benz Cars, Mercedes-Benz Vans, and Mercedes-Benz Mobility. The Mercedes-Benz Cars segment includes the brands Mercedes-AMG, Mercedes-Maybach, and Mercedes-EQ. The Mercedes-Benz Vans segment focuses on selling vans under the Mercedes-Benz brand. The Mercedes-Benz Mobility segment is involved in supporting the sales of the vehicle brands. The company was founded by Gottlieb Daimler and Carl Benz in 1926 and is headquartered in Stuttgart, Germany.

Current Price	$17.40
Prev Close	$17.39
Open	$17.44
Dividend Yield	5.81%
50-Day Moving Average	$16.70
Beta	0.77
Avg. Volume	168,729.32
PE Ratio	9.83

52-Week High	$18.12
52-Week Low	$12.55
Market Capitalization	$66.98B
EPS (Annual)	$2.75
Price to Book	0.62
Revenue Per Employee	$898,574.06
Enterprise Value/EBITDA	N/A

MBGYY
Mercedes-Benz Group AG - ADR - Unsponsored

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MBGYY News

MBGYYMercedes-Benz Group AG - ADR - Unsponsored